Effects of SlimTrack® Platform on Diet Adherence, Anthropometry and Arterial Stiffness in Postmenopausal Women
Launched by INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL · Jul 5, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a digital program called SlimTrack® on helping postmenopausal women who are overweight or obese stick to their diets, manage their weight, and improve their overall health. The trial aims to see if using the SlimTrack platform, which offers support for thoughts and emotions along with physical activities, can lead to better diet adherence and weight loss. Researchers will also look at how these changes affect the stiffness of arteries, which is an important aspect of cardiovascular health.
To participate in this study, women must be postmenopausal, overweight, or obese, and leading a sedentary lifestyle. However, those who are on hormone therapy, taking certain psychiatric medications, or have had recent surgeries or heart problems are not eligible. Participants can expect to be randomly assigned to different groups, some using the SlimTrack platform, some following a diet, and others receiving a combination of both, with weekly in-person support. This study could provide valuable insights into how digital tools can help improve health outcomes for women in this stage of life.
Gender
FEMALE
Eligibility criteria
- • Inclusion Criteria
- • Menopause
- • Overweight
- • Obesity
- • Sedentary lifestyle
- Exclusion Criteria:
- • Use of hormone therapy
- • Use of pharmacologial pshychiatric medication
- • Recent surgery (six months)
- • Recent (six months) cardiardiovascular events (myocardial infarction, stroke)
- • Adherence to diet in the last six months
- • Attending to psychoterapeutic proccess
About Instituto De Cardiologia Do Rio Grande Do Sul
The Instituto de Cardiologia do Rio Grande do Sul is a leading research and clinical institution dedicated to advancing cardiovascular health through innovative clinical trials and comprehensive patient care. Located in Brazil, the institute specializes in cardiology and is committed to enhancing the understanding and treatment of cardiovascular diseases. With a team of experienced healthcare professionals and researchers, the Instituto de Cardiologia do Rio Grande do Sul focuses on developing cutting-edge therapies and improving clinical outcomes, while fostering collaboration with national and international partners in the field of cardiovascular research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Porto Alegre, Rio Grande Do Sul, Brazil
Patients applied
Trial Officials
Fernanda Ms Poester, Graduated
Study Director
Instituto de Cardiologia RS
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported